Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 18, Issue 1, 2012, Pages 25-33

  Debruyn, Jennifer C C ^a   Hilsden, Robert ^a   Fonseca, Kevin ^b   Russell, Margaret L ^a   Kaplan, Gilaad G ^a   Vanderkooi, Otto ^a   Wrobel, Iwona ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

Author keywords

immunogenicity; inflammatory bowel disease; influenza vaccine

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; FLUVIRAL; INFLIXIMAB; INFLUENZA VACCINE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PREDNISONE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG SAFETY; ENTERITIS; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SEROLOGY; ULCERATIVE COLITIS;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; FLORIDA; FOLLOW-UP STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; VACCINATION;

EID: 83555161667     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21706     Document Type: Article

References (45)

1. Abraham C, Cho JH,. Functional consequences of NOD2 (CARD15) mutations. Inflamm Bowel Dis. 2006; 12: 641-650. (Pubitemid 43977746)
2. Aberra FN, Lichtenstein GR,. Methods to avoid infections in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11: 685-695. (Pubitemid 40961083)
3. Viget N, Vernier-Massouille G, Salmon-Ceron D, et al. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut. 2008; 57: 549-558. (Pubitemid 351442541)
4. Statistics Canada. Leading Causes of Death in Canada. Statistics Canada Catalogue number 84-215-XWE 2005. Available at:. Accessed October 1 2010.
5. Schanzer DL, Tam TWS, Langley JM, et al. Influenza-attributable deaths, Canada 1990-1999. Epidemiol Infect. 2007; 135: 1109-1116. (Pubitemid 47489721)
6. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289: 179-186. (Pubitemid 36068705)
7. Schanzer DL, Langley JM, Tam TWS,. Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals. Influenza Other Respir Viruses. 2008; 2: 1-8.
8. Schanzer DLM, Langley JMM, Tam TWSM,. Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Pediatr Infect Dis J. 2006; 25: 795-800. (Pubitemid 44334824)
9. Kwong JC,. Evaluation of the effect of Ontario's Universal Influenza Immunization Program (UIIP). Public Health Agency of Canada, Catalogue HP40-34/2008E-PDF 2008.
10. Billings JL, Hertz MI, Savik K, et al. Respiratory viruses and chronic rejection in lung transplant recipients. J Heart Lung Transpl. 2002; 21: 559-566. (Pubitemid 34451028)
11. Hassan IA, Chopra R, Swindell R, et al. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience. Bone Marrow Transplant. 2003; 32: 73-77. (Pubitemid 36850283)
12. Couch RB, Englund JA, Whimbey E,. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med. 1997; 102: 2-9.
13. Statement on Seasonal Trivalent Inactivated Influenza Vaccine for 2010-2011. Can Commun Dis Rep. 2010; 36: 1-49. Available at:. Accessed October 1 2010.
14. Prevention and control of influenza with vaccines-2010-11 recommendations of the Advisory Committee on Immunization Practices. Available at:. Accessed October 1 2010.
15. Fiore AE, Bridges CB, Cox NJ,. Seasonal influenza vaccines. Curr Top Microbiol Immunol. 2009; 333: 43-82.
16. Melmed GY, Ippoliti AF, Papadakis KA, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006; 101: 1834-1840. (Pubitemid 44166594)
17. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn's disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007; 44: 653-674.
18. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19 (suppl A): 5-36.
19. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991; 12: 439-447.
20. Hyams J, Markowitz J, Otley A, et al. Pediatric Inflammatory Bowel Disease Collaborative Research Group. Evaluation of the pediatric Crohn's disease activity index: a prospective multicenter experience. Pediatr Gastroenterol Nutr. 2005; 41: 416-421. (Pubitemid 41407602)
21. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007; 133: 423-432. (Pubitemid 47193130)
22. Statement on Seasonal Trivalent Inactivated Influenza Vaccine for 2007-2008. Can Commun Dis Rep. 2007; 36: 1-38. Available at:. Accessed October 1 2010.
23. Adverse Reactions. In: Vaccinations and Communicable Disease Control Manual. Calgary Health Region 2004: 1-13.
24. Kendal AP, Pereira MS, Shekel J,. Concepts and procedures for laboratory-based influenza surveillance. Geneva: World Health Organization; 1982.
25. Beyer WE, Palache AM, de Jong JC, et al. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine. 2002; 20: 1340-1353. (Pubitemid 34131675)
26. Mamula P, Markowitz JE, Piccoli DA, et al. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5: 851-856. (Pubitemid 47031059)
27. Lu Y, Jacobson DL, Ashworth LA, et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am J Gastroenterol. 2009; 104: 444-453.
28. Mack DR, Chartrand SA, Ruby EI, et al. Influenza vaccination following liver transplantation in children. Liver Transpl Surg. 1996; 2: 431-437. (Pubitemid 26386862)
29. Edvardsson VO, Flynn JT, Deforest A, et al. Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant. 1996; 10: 556-560. (Pubitemid 27010899)
30. Mauch TJ, Crouch NA, Freese DK, et al. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr. 1995; 127: 957-960. (Pubitemid 26003292)
31. Beyer WEP, Palache AM, Masuerl N, et al. Critical evaluation of parameters to assess the antibody response to influenza vaccination. In: Proceedings of the Abstract Book of the International Conference on Options for the Control of Influenza, Courchevel, 1992; 70.
32. Ruben FL,. Inactivated influenza virus vaccines in children. Clin Infect Dis. 2004; 38: 678-688. (Pubitemid 38333864)
33. Gelinck LB, van der Bijl AE, Beyer WE, et al. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis. 2008; 67: 713-716. (Pubitemid 351571939)
34. Fomin I, Caspi D, Levy V, et al. Vaccination against influenza in rheumatoid arthritis: The effect of disease modifying drugs, including TNF a blockers. Ann Rheum Dis. 2006; 65: 191-194. (Pubitemid 43131992)
35. Abu-Shakra M, Press J, Varsano N, et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol. 2002; 29: 2555-2557. (Pubitemid 35416961)
36. Holvast A, Huckriede A, Wilschut J, et al. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis. 2006; 65: 913-918.
37. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol. 2000; 61: 85-93. (Pubitemid 30191231)
38. Stevens R, Oliver M, Brogan M, et al. Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients. Gastroenterology. 1985; 88: 1860-1866. (Pubitemid 15052298)
39. Brogan MD, Shanahan F, Oliver M, et al. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization. J Clin Lab Immunol. 1987; 24: 69-74. (Pubitemid 18040031)
40. Kilhamn J, Brevinge H, Svennerholm AM, et al. Immune responses in ileostomy fluid and serum after oral cholera vaccination of patients colectomized because of ulcerative colitis. Infect Immun. 1998; 66: 3995-3999. (Pubitemid 28347870)
41. Kilhamn J, Lundin SB, Brevinge H, et al. T- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccine. Clin Diagn Lab Immunol. 2003; 10: 426-430. (Pubitemid 36592971)
42. Melmed GY, Agarwal N, Frenck RW, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol. 2010; 105: 148-154.
43. Melmed GY,. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis. 2009; 15: 1410-1416.
44. Sands BE, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004; 10: 677-692. (Pubitemid 39276481)
45. Lu Y, Jacobson D, Bousvaros A,. Immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009; 15: 1417-1423.